Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 211, doi. 10.1038/cgt.2013.13
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2013 AND VI 20 AND IP 4
Results: 7
1
2
Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 260, doi. 10.1038/cgt.2013.15
- By:
- Publication type:
- Article
3
Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 237, doi. 10.1038/cgt.2013.11
- By:
- Publication type:
- Article
4
Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 242, doi. 10.1038/cgt.2013.12
- By:
- Publication type:
- Article
5
Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 229, doi. 10.1038/cgt.2013.10
- By:
- Publication type:
- Article
6
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 222, doi. 10.1038/cgt.2013.9
- By:
- Publication type:
- Article
7
Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 4, p. 251, doi. 10.1038/cgt.2013.14
- By:
- Publication type:
- Article